Columbia Partners Investment Management’s Kite Pharma, Inc. KITE Stock Holding History

Columbia Partners Investment Management’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-68,801	Closed	-$3.44M	–	387
2016 Q2	$3.44M	Buy	68,801 +10,579	+18%	+$520K	0.26%	127
2016 Q1	$2.67M	Buy	58,222 +2,378	+4%	+$115K	0.19%	146
2015 Q4	$3.44M	Sell	55,844 -19,398	-26%	-$1.37M	0.24%	124
2015 Q3	$4.19M	Sell	75,242 -98,568	-57%	-$6.2M	0.29%	117
2015 Q2	$10.6M	Buy	173,810 +32,450	+23%	+$1.85M	0.65%	49
2015 Q1	$8.15M	Buy	141,360 +34,582	+32%	+$2.32M	0.43%	92
2014 Q4	$6.16M	Buy	+106,778	New	+$4.5M	0.32%	115

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Columbia Partners Investment Management's KITE Position: Q3 2016 in Review

Columbia Partners Investment Management sold out of Kite Pharma, Inc. (KITE) in Q3 2016, closing a stake of 68,801 shares — an estimated $3.44M sold.

Columbia Partners Investment Management first reported a position in KITE in Q4 2014 and held it in 7 quarters. The position peaked at $10.6M in Q2 2015. 195 funds tracked by Wall St. Rank hold KITE as of Q3 2016.

Columbia Partners Investment Management reported no remaining Kite Pharma, Inc. position as of Q3 2016 after selling out during the quarter.
Columbia Partners Investment Management sold 68,801 Kite Pharma, Inc. shares in Q3 2016, an estimated $3.44M.
Columbia Partners Investment Management first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 7 quarters.
Columbia Partners Investment Management's Kite Pharma, Inc. position peaked at $10.6M in Q2 2015.
195 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2016.

Based on Columbia Partners Investment Management's 13F filing for Q3 2016, filed 14 Nov 2016.